Summary of Drug Coverage Location - Georgia SHBP

Size: px
Start display at page:

Download "Summary of Drug Coverage Location - Georgia SHBP"

Transcription

1 Summary of Drug Coverage Location - Georgia SHBP Last Update: 12/07/2015 Therapeutic Category Description Trade Name Description SHBP Coverage Location Route Description Date of Revision to Document ADJUNCTIVE AGENTS LEVOLEUCOVORIN CALCIUM medical INTRAVENOUS 6/1/2015 ADRENAL HORMONES BETA 1 medical INJECTION 10/8/2015 ADRENAL HORMONES PRO-C-DURE 5 medical INJECTION 10/8/2015 ADRENAL HORMONES TRIAMCINOLONE ACETONIDE medical INJECTION 6/5/2014 ADRENOCORTICOTROPHIC HORMONES ACTHAR H.P. both INJECTION AGENTS TO TREAT MULTIPLE SCLEROSIS AUBAGIO pharmacy ORAL AGENTS TO TREAT MULTIPLE SCLEROSIS AVONEX ADMINISTRATION PACK pharmacy INTRAMUSCULAR AGENTS TO TREAT MULTIPLE SCLEROSIS AVONEX PEN pharmacy INTRAMUSCULAR AGENTS TO TREAT MULTIPLE SCLEROSIS BETASERON pharmacy SUBCUTANEOUS AGENTS TO TREAT MULTIPLE SCLEROSIS COPAXONE pharmacy SUBCUTANEOUS AGENTS TO TREAT MULTIPLE SCLEROSIS EXTAVIA pharmacy SUBCUTANEOUS AGENTS TO TREAT MULTIPLE SCLEROSIS GILENYA pharmacy ORAL AGENTS TO TREAT MULTIPLE SCLEROSIS REBIF pharmacy SUBCUTANEOUS AGENTS TO TREAT MULTIPLE SCLEROSIS REBIF REBIDOSE pharmacy SUBCUTANEOUS AGENTS TO TREAT MULTIPLE SCLEROSIS TECFIDERA pharmacy ORAL AGTS TX NEUROMUSC TRANSMISSION DIS,POT-CHAN BLKR AMPYRA pharmacy ORAL ALKYLATING AGENTS ALKERAN medical INTRAVENOUS ALKYLATING AGENTS BICNU medical INTRAVENOUS ALKYLATING AGENTS BUSULFEX medical INTRAVENOUS ALKYLATING AGENTS CARBOPLATIN medical INTRAVENOUS ALKYLATING AGENTS CISPLATIN medical INTRAVENOUS ALKYLATING AGENTS CYCLOPHOSPHAMIDE medical INTRAVENOUS ALKYLATING AGENTS ELOXATIN medical INTRAVENOUS ALKYLATING AGENTS IFEX medical INTRAVENOUS ALKYLATING AGENTS IFOSFAMIDE medical INTRAVENOUS ALKYLATING AGENTS IFOSFAMIDE-MESNA medical INTRAVENOUS ALKYLATING AGENTS MELPHALAN HCL medical INTRAVENOUS ALKYLATING AGENTS MUSTARGEN medical INJECTION ALKYLATING AGENTS OXALIPLATIN medical INTRAVENOUS ALKYLATING AGENTS TEMODAR medical INTRAVENOUS ALKYLATING AGENTS THIOTEPA medical INJECTION ALKYLATING AGENTS TREANDA medical INTRAVENOUS ALKYLATING AGENTS pharmacy ORAL AMINOGLYCOSIDES TOBI pharmacy INHALATION AMINOGLYCOSIDES TOBI PODHALER pharmacy INHALATION AMMONIA INHIBITORS CARBAGLU pharmacy ORAL 1

2 AMYOTROPHIC LATERAL SCLEROSIS AGENTS RILUTEK pharmacy ORAL ANALGESICS, NARCOTICS MORPHINE SULFATE medical INTRAVENOUS 5/8/2014 ANALGESICS, NARCOTICS ONSOLIS pharmacy BUCCAL ANALGESICS, NEURONAL-TYPE CALCIUM CHANNEL BLOCKERS PRIALT medical INTRATHECAL ANDROGENIC AGENTS AVEED medical INTRAMUSCULAR 3/24/2014 ANDROGENIC AGENTS TESTOPEL medical IMPLANTATION ANTI-ALCOHOLIC PREPARATIONS VIVITROL medical INTRAMUSCULAR ANTIANDROGENIC AGENTS XTANDI pharmacy ORAL ANTIANDROGENIC AGENTS ZYTIGA pharmacy ORAL ANTIARRHYTHMICS, OTHER ADENOSINE medical INTRAVENOUS 3/24/2014 ANTIBIOTIC ANTINEOPLASTICS ADRIAMYCIN medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS BLEOMYCIN SULFATE medical INJECTION ANTIBIOTIC ANTINEOPLASTICS CERUBIDINE medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS COSMEGEN medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS DACTINOMYCIN medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS DAUNORUBICIN HCL medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS DAUNOXOME medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS DOXIL medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS DOXORUBICIN HCL medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS ELLENCE medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS EPIRUBICIN HCL medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS IDAMYCIN PFS medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS IDARUBICIN HCL medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS LIPODOX medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS MITOMYCIN medical INTRAVENOUS ANTIBIOTIC ANTINEOPLASTICS VALSTAR medical INTRAVESICAL ANTIBIOTIC ANTINEOPLASTICS ZANOSAR medical INTRAVENOUS ANTI-CD20 (B LYMPHOCYTE) MONOCLONAL ANTIBODY ARZERRA medical INTRAVENOUS ANTI-CD20 (B LYMPHOCYTE) MONOCLONAL ANTIBODY RITUXAN medical INTRAVENOUS ANTICOAGULANTS ARGATROBAN medical INTRAVENOUS 6/1/2015 ANTICONVULSANTS SABRIL pharmacy ORAL ANTIDIURETIC AND VASOPRESSOR HORMONES DDAVP medical INJECTION ANTIDIURETIC AND VASOPRESSOR HORMONES DESMOPRESSIN ACETATE medical INJECTION ANTIDIURETIC AND VASOPRESSOR HORMONES Stimate Nasal Spray pharmacy intranasal 3/6/2015 ANTIFIBRINOLYTIC AGENTS RIASTAP medical INTRAVENOUS ANTIFUNGAL AGENTS CRESEMBA medical INTRAVENOUS 5/6/2015 ANTIFUNGAL AGENTS NOXAFIL medical INTRAVENOUS 5/8/2014 ANTIHEMOPHILIC FACTORS ADVATE both INTRAVENOUS 4/21/2014 2

3 ANTIHEMOPHILIC FACTORS ADVATE H both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS ADVATE L both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS ADVATE M both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS ADVATE SH both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS ADVATE UH both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS ALPHANATE both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS FEIBA NF both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS FEIBA VH IMMUNO both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS HELIXATE FS both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS HEMOFIL-M both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS HUMATE-P both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS KOATE-DVI both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS KOGENATE FS both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS MONARC-M both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS MONOCLATE-P both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS NOVOSEVEN both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS NOVOSEVEN RT both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS RECOMBINATE both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS TRETTEN both INTRAVENOUS 5/8/2014 ANTIHEMOPHILIC FACTORS XYNTHA both INTRAVENOUS 4/21/2014 ANTIHEMOPHILIC FACTORS XYNTHA SOLOFUSE both INTRAVENOUS 4/21/2014 ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE & BIGUANIDE AVANDAMET pharmacy ORAL ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE & SULFONYLUREA AVANDARYL pharmacy ORAL ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE(PPARG AGONIST) AVANDIA pharmacy ORAL ANTI-INFLAM. INTERLEUKIN-1 RECEPTOR ANTAGONIST ARCALYST pharmacy (w/qll) SUBCUTANEOUS ANTI-INFLAM. INTERLEUKIN-1 RECEPTOR ANTAGONIST KINERET pharmacy SUBCUTANEOUS ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR ENBREL pharmacy SUBCUTANEOUS ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR HUMIRA pharmacy SUBCUTANEOUS ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR SIMPONI pharmacy SUBCUTANEOUS ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR SIMPONI ARIA medical INTRAVENOUS 3/24/2014 ANTI-INFLAMMATORY, INTERLEUKIN-1 BETA BLOCKERS ILARIS pharmacy SUBCUTANEOUS ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. EUFLEXXA medical INTRAARTICULAR ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. GEL-ONE medical INTRAARTICULAR 4/21/2014 ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. HYALGAN medical INTRAARTICULAR ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. ORTHOVISC medical INTRAARTICULAR ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. SUPARTZ medical INTRAARTICULAR ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. SYNVISC medical INTRAARTICULAR ANTI-INFLAMMATORY/ANTIARTHRITICS AGENTS, MISC. SYNVISC-ONE medical INTRAARTICULAR 3

4 ANTILEPROTICS THALOMID pharmacy ORAL ANTIMETABOLITES ADRUCIL medical INTRAVENOUS ANTIMETABOLITES ALIMTA medical INTRAVENOUS ANTIMETABOLITES ARRANON medical INTRAVENOUS ANTIMETABOLITES CLADRIBINE medical INTRAVENOUS ANTIMETABOLITES CLOLAR medical INTRAVENOUS ANTIMETABOLITES CYTARABINE medical INJECTION ANTIMETABOLITES DACOGEN both INTRAVENOUS ANTIMETABOLITES DEPOCYT medical INTRATHECAL ANTIMETABOLITES FLOXURIDINE medical INJECTION ANTIMETABOLITES FLUDARA medical INTRAVENOUS ANTIMETABOLITES FLUDARABINE PHOSPHATE medical INTRAVENOUS ANTIMETABOLITES FLUOROURACIL medical INTRAVENOUS ANTIMETABOLITES FOLOTYN medical INTRAVENOUS ANTIMETABOLITES GEMCITABINE HCL medical INTRAVENOUS ANTIMETABOLITES GEMZAR medical INTRAVENOUS ANTIMETABOLITES LEUSTATIN medical INTRAVENOUS ANTIMETABOLITES METHOTREXATE medical INJECTION ANTIMETABOLITES METHOTREXATE SODIUM medical INJECTION ANTIMETABOLITES NIPENT medical INTRAVENOUS ANTIMETABOLITES OFORTA pharmacy ORAL ANTIMETABOLITES PENTOSTATIN medical INTRAVENOUS 4/21/2014 ANTIMETABOLITES PURIXAN pharmacy ORAL 7/7/2014 ANTIMETABOLITES VIDAZA medical INJECTION ANTIMETABOLITES XELODA pharmacy ORAL ANTI-NARCOLEPSY & ANTI-CATAPLEXY,SEDATIVE-TYPE AGT XYREM pharmacy ORAL ANTINEOPLAST HUM VEGF INHIBITOR RECOMB MC ANTIBODY AVASTIN medical INTRAVENOUS ANTINEOPLAST,HISTONE DEACETYLASE (HDAC) INHIBITORS ISTODAX medical INTRAVENOUS ANTINEOPLAST,HISTONE DEACETYLASE (HDAC) INHIBITORS ZOLINZA pharmacy ORAL ANTINEOPLASTIC - EPOTHILONES AND ANALOGS IXEMPRA medical INTRAVENOUS ANTINEOPLASTIC - HALICHONDRIN B ANALOGS HALAVEN medical INTRAVENOUS ANTINEOPLASTIC - HEDGEHOG PATHWAY INHIBITOR ERIVEDGE pharmacy ORAL ANTINEOPLASTIC - IMMUNOTHERAPY, THERAPEUTIC VAC SIPULEUCEL-T PROVENGE medical INTRAVENOUS ANTINEOPLASTIC - JANUS KINASE (JAK) INHIBITORS JAKAFI pharmacy ORAL ANTINEOPLASTIC - MTOR KINASE INHIBITORS AFINITOR pharmacy ORAL ANTINEOPLASTIC - MTOR KINASE INHIBITORS TORISEL medical INTRAVENOUS ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS CAMPTOSAR medical INTRAVENOUS ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS HYCAMTIN medical INTRAVENOUS 4

5 ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS IRINOTECAN HCL medical INTRAVENOUS ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS TOPOTECAN HCL medical INTRAVENOUS ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS pharmacy ORAL ANTINEOPLASTIC - VEGF-A,B & PLGF INHIBITOR ZALTRAP medical INTRAVENOUS ANTINEOPLASTIC DRUGS CYRAMZA medical INTRAVENOUS 5/8/2014 ANTINEOPLASTIC DRUGS CYRAMZA medical INTRAVENOUS 6/5/2014 ANTINEOPLASTIC DRUGS Kadcyla medical INTRAVENOUS 5/12/2014 ANTINEOPLASTIC DRUGS SYLVANT medical INTRAVENOUS 6/5/2014 ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY ERBITUX medical INTRAVENOUS ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY HERCEPTIN medical INTRAVENOUS ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY PERJETA medical INTRAVENOUS ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY VECTIBIX medical INTRAVENOUS ANTINEOPLASTIC IMMUNOMODULATOR AGENTS POMALYST pharmacy ORAL ANTINEOPLASTIC IMMUNOMODULATOR AGENTS REVLIMID pharmacy ORAL ANTINEOPLASTIC IMMUNOMODULATOR AGENTS SYLATRON both SUBCUTANEOUS ANTINEOPLASTIC IMMUNOMODULATOR AGENTS SYLATRON 4-PACK both SUBCUTANEOUS ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. ELIGARD medical SUBCUTANEOUS - MD inj only 4/21/2014 ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. LEUPROLIDE ACETATE pharmacy SUBCUTANEOUS ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. LUPANETA PACK medical INTRAMUSCULAR 3/24/2014 ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. LUPRON DEPOT medical INTRAMUSCULAR ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. TRELSTAR medical INTRAMUSCULAR ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. TRELSTAR DEPOT medical INTRAMUSCULAR ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. TRELSTAR LA medical INTRAMUSCULAR ANTINEOPLASTIC LHRH(GNRH) AGONIST,PITUITARY SUPPR. ZOLADEX medical SUBCUTANEOUS ANTINEOPLASTIC LHRH(GNRH) ANTAGONIST,PITUIT.SUPPRS FIRMAGON both SUBCUTANEOUS ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS BOSULIF pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS GLEEVEC pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS INLYTA pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS KYPROLIS medical INTRAVENOUS ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS MEKINIST pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS NEXAVAR pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS SPRYCEL pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS STIVARGA pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS SUTENT pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS TAFINLAR pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS TARCEVA pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS TASIGNA pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS TYKERB pharmacy ORAL 5

6 ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS VANDETANIB pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS VELCADE medical INJECTION ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS VOTRIENT pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS XALKORI pharmacy ORAL ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS ZELBORAF pharmacy ORAL ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES ADCETRIS medical INTRAVENOUS ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES BEXXAR medical INTRAVENOUS ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES MYLOTARG medical INTRAVENOUS ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES ZEVALIN medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS ABRAXANE medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS DACARBAZINE medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS DOCEFREZ medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS DOCETAXEL medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS ELSPAR medical INJECTION ANTINEOPLASTICS,MISCELLANEOUS ERWINAZE medical INTRAMUSCULAR ANTINEOPLASTICS,MISCELLANEOUS ETOPOPHOS medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS ETOPOSIDE medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS JEVTANA medical INTRAVENOUS 3/28/2014 ANTINEOPLASTICS,MISCELLANEOUS MITOXANTRONE medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS NOVANTRONE medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS ONCASPAR medical INJECTION ANTINEOPLASTICS,MISCELLANEOUS ONTAK medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS ONXOL medical INTRAVENOUS 4/21/2014 ANTINEOPLASTICS,MISCELLANEOUS PACLITAXEL medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS TAXOTERE medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS TENIPOSIDE medical INTRAVENOUS 4/21/2014 ANTINEOPLASTICS,MISCELLANEOUS THERACYS medical INTRAVESICAL ANTINEOPLASTICS,MISCELLANEOUS TICE BCG medical INTRAVESICAL ANTINEOPLASTICS,MISCELLANEOUS TOPOSAR medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS TRISENOX medical INTRAVENOUS ANTINEOPLASTICS,MISCELLANEOUS VUMON medical INTRAVENOUS ANTINEOPLASTICS/IMMUNOSUPPRESANT DRUGS GAZYVA medical INTRAVENOUS 3/24/2014 ANTINFLAMMATORY, SEL.COSTIM.MOD.,T-CELL INHIBITOR ORENCIA both INTRAVENOUS ANTINFLAMMATORY, SEL.COSTIM.MOD.,T-CELL INHIBITOR pharmacy SUBCUTANEOUS ANTI-OBESITY - ANOREXIC AGENTS QSYMIA Not covered ORAL ANTIPARKINSONISM AGENTS DUOPA medical MISCELLANEOUS 3/6/2015 ANTIPARKINSONISM DRUGS,OTHER APOKYN pharmacy SUBCUTANEOUS ANTIPLATELET DRUGS KENGREAL medical INTRAVENOUS 7/8/2015 6

7 ANTIPSORIATIC / ANTISEBORRHEIC COSENTYX pharmacy SUBCUTANEOUS 3/6/2015 ANTIPSORIATIC AGENTS,SYSTEMIC 8-MOP pharmacy ORAL ANTIPSORIATIC AGENTS,SYSTEMIC AMEVIVE medical INTRAMUSCULAR ANTISERA ATGAM medical INTRAVENOUS ANTISERA BIVIGAM medical INTRAVENOUS 4/21/2014 ANTISERA CARIMUNE NF NANOFILTERED medical INTRAVENOUS ANTISERA CYTOGAM medical INTRAVENOUS ANTISERA FLEBOGAMMA medical INTRAVENOUS ANTISERA FLEBOGAMMA DIF medical INTRAVENOUS ANTISERA GAMASTAN S-D medical INTRAMUSCULAR ANTISERA GAMMAGARD LIQUID medical INTRAVENOUS ANTISERA GAMMAGARD S-D medical INTRAVENOUS ANTISERA GAMMAKED medical INJECTION ANTISERA GAMMAPLEX medical INTRAVENOUS ANTISERA GAMUNEX medical INTRAVENOUS ANTISERA GAMUNEX-C medical INJECTION ANTISERA HEPAGAM B medical INJECTION ANTISERA HIZENTRA both SUBCUTANEOUS 3/28/2014 ANTISERA HYPERHEP B S-D medical INTRAMUSCULAR ANTISERA HYPERRAB S-D medical INTRAMUSCULAR ANTISERA HYPERRHO S-D medical INTRAMUSCULAR ANTISERA IMOGAM RABIES-HT medical INTRAMUSCULAR ANTISERA MICRHOGAM PLUS medical INTRAMUSCULAR ANTISERA NABI-HB medical INTRAMUSCULAR ANTISERA OCTAGAM medical INTRAVENOUS ANTISERA PRIVIGEN medical INTRAVENOUS ANTISERA RHOGAM PLUS medical INTRAMUSCULAR ANTISERA RHOPHYLAC medical INJECTION ANTISERA THYMOGLOBULIN medical INTRAVENOUS ANTISERA VIVAGLOBIN medical SUBCUTANEOUS ANTISERA WINRHO SDF medical INJECTION ANTIVIRAL MONOCLONAL ANTIBODIES SYNAGIS both INTRAMUSCULAR 4/21/2014 ANTIVIRALS, HIV-SPECIFIC, FUSION INHIBITORS FUZEON pharmacy SUBCUTANEOUS ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI RETROVIR medical INTRAVENOUS ARGININE VASOPRESSIN (AVP) RECEPTOR ANTAGONISTS SAMSCA pharmacy ORAL BETALACTAMS CAYSTON pharmacy INHALATION BILE SALTS CHENODAL pharmacy ORAL BLOOD DERIVATIVES FLEXBUMIN medical INTRAVENOUS 10/9/2014 7

8 BLOOD FACTORS,MISCELLANEOUS CORIFACT medical INTRAVENOUS BONE FORMATION STIM. AGENTS - PARATHYROID HORMONE FORTEO pharmacy SUBCUTANEOUS BONE RESORPTION INHIBITORS AREDIA medical INTRAVENOUS BONE RESORPTION INHIBITORS BONIVA medical INTRAVENOUS BONE RESORPTION INHIBITORS IBANDRONATE medical INTRAVENOUS 4/21/2014 BONE RESORPTION INHIBITORS PAMIDRONATE DISODIUM medical INTRAVENOUS BONE RESORPTION INHIBITORS PROLIA medical SUBCUTANEOUS BONE RESORPTION INHIBITORS RECLAST medical INTRAVENOUS BONE RESORPTION INHIBITORS XGEVA medical SUBCUTANEOUS BONE RESORPTION INHIBITORS ZOLEDRONIC ACID medical INTRAVENOUS BONE RESORPTION INHIBITORS ZOMETA medical INTRAVENOUS BRADYKININ B2 RECEPTOR ANTAGONISTS FIRAZYR pharmacy SUBCUTANEOUS C1 ESTERASE INHIBITORS BERINERT both INTRAVENOUS C1 ESTERASE INHIBITORS CINRYZE medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS AMIFOSTINE medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS CALCIUM FOLINATE medical INJECTION CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS DEXRAZOXANE medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS ETHYOL medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS FUSILEV medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS LEUCOVORIN CALCIUM medical INJECTION CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS MESNA medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS MESNEX medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS ZINECARD medical INTRAVENOUS CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS pharmacy ORAL COMBINATION NARCOTIC /ANALGESICS APAP-CAFFEINE-DIHYDROCODEINE medical ORAL 9/10/2015 CONTRACEPTIVES,IMPLANTABLE IMPLANON medical SUBCUTANEOUS CONTRACEPTIVES,IMPLANTABLE NEXPLANON medical SUBCUTANEOUS contrast agent GADAVIST medical INTRAVENOUS contrast agent ISOVUE medical INTRAVENOUS 6/5/2014 CXCR4 CHEMOKINE RECEPTOR ANTAGONIST MOZOBIL both SUBCUTANEOUS CYSTIC FIB.TRANSMEMB CONDUCT.REG.(CFTR)POTENTIATOR KALYDECO pharmacy ORAL CYTOTOXIC T-LYMPHOCYTE ANTIGEN(CTLA-4)RMC ANTIBODY YERVOY medical INTRAVENOUS DIAGNOSTIC PRODUCT MD-GASTROVIEW 66%-10% SOLN medical 3/24/2014 DIAPHRAGMS AND OTHER NON-ORAL CONTRACEPTIVES LILETTA medical INTRAUTERINE 4/10/2015 DRUGS TO TREAT HEREDITARY TYROSINEMIA ORFADIN pharmacy ORAL DRUGS TO TX CHRONIC INFLAMMATORY DISEASE OF COLON CIMZIA pharmacy SUBCUTANEOUS DRUGS TO TX CHRONIC INFLAMMATORY DISEASE OF COLON REMICADE medical INTRAVENOUS DRUGS TO TX GAUCHER DX-TYPE 1, SUBSTRATE REDUCING ZAVESCA pharmacy ORAL 8

9 ERYTHROPOIESIS-STIMULATING AGENTS ARANESP both INJECTION ERYTHROPOIESIS-STIMULATING AGENTS EPOGEN both INJECTION ERYTHROPOIESIS-STIMULATING AGENTS OMONTYS medical INJECTION ERYTHROPOIESIS-STIMULATING AGENTS PROCRIT both INJECTION FACTOR IX PREPARATIONS ALPHANINE SD both INTRAVENOUS 4/21/2014 FACTOR IX PREPARATIONS BEBULIN both INTRAVENOUS 4/21/2014 FACTOR IX PREPARATIONS BEBULIN VH IMMUNO both INTRAVENOUS 4/21/2014 FACTOR IX PREPARATIONS BENEFIX both INTRAVENOUS 4/21/2014 FACTOR IX PREPARATIONS MONONINE both INTRAVENOUS 4/21/2014 FACTOR IX PREPARATIONS PROFILNINE SD both INTRAVENOUS 4/21/2014 FLUOROQUINOLONES MOXIFLOXACIN HCL medical INTRAVENOUS 9/10/2015 FOLLICLE-STIMULATING & LUTEINIZING HORMONES MENOPUR pharmacy - under appeal SUBCUTANEOUS FOLLICLE-STIMULATING & LUTEINIZING HORMONES REPRONEX pharmacy - under appeal INJECTION FOLLICLE-STIMULATING HORMONE (FSH) BRAVELLE pharmacy - under appeal INJECTION FOLLICLE-STIMULATING HORMONE (FSH) FOLLISTIM AQ pharmacy - under appeal INJECTION FOLLICLE-STIMULATING HORMONE (FSH) GONAL-F pharmacy - under appeal SUBCUTANEOUS FOLLICLE-STIMULATING HORMONE (FSH) GONAL-F RFF pharmacy - under appeal SUBCUTANEOUS FOLLICLE-STIMULATING HORMONE (FSH) GASTRIC ENZYMES SUCRAID pharmacy ORAL SUBCUTANEOUS GROWTH HORMONE RECEPTOR ANTAGONISTS SOMAVERT pharmacy SUBCUTANEOUS GROWTH HORMONE RELEASING HORMONE (GHRH) & ANALOGS EGRIFTA pharmacy SUBCUTANEOUS GROWTH HORMONES GENOTROPIN pharmacy SUBCUTANEOUS GROWTH HORMONES HUMATROPE pharmacy INJECTION GROWTH HORMONES NORDITROPIN pharmacy SUBCUTANEOUS GROWTH HORMONES NORDITROPIN FLEXPRO pharmacy SUBCUTANEOUS GROWTH HORMONES NORDITROPIN NORDIFLEX pharmacy SUBCUTANEOUS GROWTH HORMONES NUTROPIN pharmacy SUBCUTANEOUS GROWTH HORMONES NUTROPIN AQ pharmacy SUBCUTANEOUS GROWTH HORMONES NUTROPIN AQ NUSPIN pharmacy SUBCUTANEOUS GROWTH HORMONES OMNITROPE pharmacy SUBCUTANEOUS GROWTH HORMONES SAIZEN pharmacy SUBCUTANEOUS GROWTH HORMONES SEROSTIM pharmacy SUBCUTANEOUS GROWTH HORMONES TEV-TROPIN pharmacy SUBCUTANEOUS GROWTH HORMONES ZOMACTON pharmacy SUBCUTANEOUS 6/1/2015 GROWTH HORMONES ZOMACTON pharmacy SUBCUTANEOUS 7/8/2015 GROWTH HORMONES ZORBTIVE pharmacy SUBCUTANEOUS HEMOSTATICS CYKLOKAPRON medical INTRAVENOUS 3/6/2015 HEPARIN AND RELATED PREPARATIONS ARIXTRA Both SUBCUTANEOUS 9/10/2015 9

10 HEPARIN AND RELATED PREPARATIONS ENOXAPARIN SODIUM Both SUBCUTANEOUS 9/10/2015 HEPARIN AND RELATED PREPARATIONS FONDAPARINUX SODIUM Both SUBCUTANEOUS 9/10/2015 HEPARIN AND RELATED PREPARATIONS FRAGMIN Both SUBCUTANEOUS 9/10/2015 HEPARIN AND RELATED PREPARATIONS INNOHEP Both SUBCUTANEOUS 9/10/2015 HEPARIN AND RELATED PREPARATIONS LOVENOX both SUBCUTANEOUS 9/10/2015 HEPATITIS C TREATMENT AGENTS COPEGUS pharmacy ORAL HEPATITIS C TREATMENT AGENTS INFERGEN pharmacy SUBCUTANEOUS HEPATITIS C TREATMENT AGENTS PEGASYS pharmacy SUBCUTANEOUS HEPATITIS C TREATMENT AGENTS PEGASYS PROCLICK pharmacy SUBCUTANEOUS HEPATITIS C TREATMENT AGENTS PEG-INTRON pharmacy SUBCUTANEOUS HEPATITIS C TREATMENT AGENTS PEG-INTRON REDIPEN pharmacy SUBCUTANEOUS HEPATITIS C TREATMENT AGENTS REBETOL pharmacy ORAL HEPATITIS C TREATMENT AGENTS RIBAPAK pharmacy ORAL HEPATITIS C TREATMENT AGENTS RIBASPHERE pharmacy ORAL HEPATITIS C TREATMENT AGENTS RIBATAB pharmacy ORAL HEPATITIS C TREATMENT AGENTS RIBAVIRIN pharmacy ORAL HEPATITIS C VIRUS NS3/4A SERINE PROTEASE INHIB. INCIVEK pharmacy ORAL HEPATITIS C VIRUS NS3/4A SERINE PROTEASE INHIB. VICTRELIS pharmacy ORAL HUMAN CHORIONIC GONADOTROPIN (HCG) CHORIONIC GONADOTROPIN medical INTRAMUSCULAR HUMAN CHORIONIC GONADOTROPIN (HCG) NOVAREL medical INTRAMUSCULAR HUMAN CHORIONIC GONADOTROPIN (HCG) OVIDREL medical SUBCUTANEOUS HUMAN CHORIONIC GONADOTROPIN (HCG) PREGNYL medical INTRAMUSCULAR HUMAN MONOCLONAL ANTIBODY COMPLEMENT(C5) INHIBITOR SOLIRIS medical INTRAVENOUS HYPERURICEMIA TX - URATE-OXIDASE ENZYME-TYPE ELITEK medical INTRAVENOUS HYPERURICEMIA TX - URATE-OXIDASE ENZYME-TYPE KRYSTEXXA medical INTRAVENOUS HYPNOTIC AGENTS DEXMEDETOMIDINE HCL medical INTRAVENOUS 9/8/2014 HYPNOTIC AGENTS PRECEDEX medical INTRAVENOUS 3/6/2015 Both - Medical should only cover IMMUNOLOGICALS AND VACCINES GRASTEK SUBLINGUAL 2/3/2015 1st dose Both - Medical should only cover IMMUNOLOGICALS AND VACCINES ORALAIR SUBLINGUAL 2/3/2015 1st dose Both - Medical should only cover IMMUNOLOGICALS AND VACCINES RAGWITEK SUBLINGUAL 2/3/2015 1st dose IMMUNOMODULATOR,B-LYMPHOCYTE STIM(BLYS)-SPEC INHIB BENLYSTA medical INTRAVENOUS IMMUNOMODULATORS ACTIMMUNE pharmacy SUBCUTANEOUS IMMUNOMODULATORS ALFERON N pharmacy INJECTION IMMUNOMODULATORS INTRON A pharmacy INJECTION IMMUNOMODULATORS PROLEUKIN medical INTRAVENOUS IMMUNOSUPP - MONOCLONAL AB INHIBITING T LYMPH FXN ORTHOCLONE OKT-3 medical INTRAVENOUS IMMUNOSUPP - MONOCLONAL AB INHIBITING T LYMPH FXN SIMULECT medical INTRAVENOUS IMMUNOSUPPRESSIVES CELLCEPT medical INTRAVENOUS 3/24/

11 IMMUNOSUPPRESSIVES CELLCEPT pharmacy ORAL 3/24/2014 IMMUNOSUPPRESSIVES CYCLOSPORINE pharmacy ORAL 3/24/2014 IMMUNOSUPPRESSIVES CYCLOSPORINE medical INTRAVENOUS 3/24/2014 IMMUNOSUPPRESSIVES NULOJIX medical INTRAVENOUS IMMUNOSUPPRESSIVES PROGRAF pharmacy ORAL 3/24/2014 IMMUNOSUPPRESSIVES PROGRAF medical INTRAVENOUS 3/24/2014 IMMUNOSUPPRESSIVES SANDIMMUNE pharmacy ORAL 3/24/2014 IMMUNOSUPPRESSIVES SANDIMMUNE medical INTRAVENOUS 3/24/2014 INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) HORMONES INCRELEX pharmacy SUBCUTANEOUS INTERLEUKIN-6 (IL-6) RECEPTOR INHIBITORS ACTEMRA medical INTRAVENOUS INTRA-UTERINE DEVICES (IUDS) MIRENA medical INTRAUTERINE INTRA-UTERINE DEVICES (IUDS) SKYLA medical INTRAUTERINE IRRITANTS/COUNTER-IRRITANTS QUTENZA pharmacy TOPICAL JANUS KINASE (JAK) INHIBITORS XELJANZ pharmacy ORAL JOINT CONTRACTURE THERAPY, COLLAGENASE ENZYME XIAFLEX medical INJECTION KERATINOCYTE GROWTH FACTOR (KGF) KEPIVANCE medical INTRAVENOUS KIDNEY STONE AGENTS CYSTAGON pharmacy ORAL KIDNEY STONE AGENTS PROCYSBI pharmacy ORAL LEUKOCYTE (WBC) STIMULANTS LEUKINE both INJECTION LEUKOCYTE (WBC) STIMULANTS NEULASTA both SUBCUTANEOUS LEUKOCYTE (WBC) STIMULANTS NEUPOGEN both INJECTION LEUKOCYTE ADHESION INHIB,ALPHA4-MEDIAT IGG4K MC AB TYSABRI medical INTRAVENOUS LHRH (GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS LUPRON DEPOT medical INTRAMUSCULAR LHRH (GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS SUPPRELIN LA medical IMPLANTATION LHRH (GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS VANTAS medical IMPLANTATION LHRH(GNRH) ANTAGONIST,PITUITARY SUPPRESSANT AGENTS CETROTIDE pharmacy - under appeal SUBCUTANEOUS LHRH(GNRH) ANTAGONIST,PITUITARY SUPPRESSANT AGENTS GANIRELIX ACETATE pharmacy - under appeal SUBCUTANEOUS LHRH(GNRH)AGNST PIT.SUP-CENTRAL PRECOCIOUS PUBERTY LUPRON DEPOT-PED medical INTRAMUSCULAR LIPID/CHOLESTEROL LOWERING AGENTS PRALUENT pharmacy SUBCUTANEOUS 8/5/2015 LIPID/CHOLESTEROL LOWERING AGENTS REPATHA SURECLICK pharmacy SUBCUTANEOUS 9/10/2015 LIPID/CHOLESTEROL LOWERING AGENTS REPATHA SYRINGE pharmacy SUBCUTANEOUS 9/10/2015 LUTEINIZING HORMONES LUVERIS pharmacy - under appeal SUBCUTANEOUS METABOLIC DISEASE ENZYME REPLACEMENT, FABRY'S DX FABRAZYME medical INTRAVENOUS METABOLIC DISEASE ENZYME REPLACEMENT, GAUCHER'S DX CEREDASE medical INTRAVENOUS METABOLIC DISEASE ENZYME REPLACEMENT, GAUCHER'S DX CEREZYME medical INTRAVENOUS METABOLIC DISEASE ENZYME REPLACEMENT, GAUCHER'S DX ELELYSO medical INTRAVENOUS METABOLIC DISEASE ENZYME REPLACEMENT, GAUCHER'S DX VPRIV medical INTRAVENOUS METABOLIC DISEASE ENZYME REPLACEMENT,POMPE DISEASE LUMIZYME medical INTRAVENOUS 11

12 METABOLIC DISEASE ENZYME REPLACEMENT,POMPE DISEASE MYOZYME medical INTRAVENOUS METABOLIC DX ENZYME REPLACE, MUCOPOLYSACCHARIDOSIS ALDURAZYME medical INTRAVENOUS METABOLIC DX ENZYME REPLACE, MUCOPOLYSACCHARIDOSIS ELAPRASE medical INTRAVENOUS METABOLIC DX ENZYME REPLACE, MUCOPOLYSACCHARIDOSIS NAGLAZYME medical INTRAVENOUS METABOLIC DX ENZYME REPLACEMT,SEV.COMB.IMMUNE DEF. ADAGEN medical INTRAMUSCULAR METALLIC POISON,AGENTS TO TREAT CALCIUM DISODIUM VERSENATE medical INTRAVENOUS 3/24/2014 METALLIC POISON,AGENTS TO TREAT DEFEROXAMINE MESYLATE medical INJECTION METALLIC POISON,AGENTS TO TREAT DESFERAL medical INJECTION METALLIC POISON,AGENTS TO TREAT EXJADE pharmacy ORAL METALLIC POISON,AGENTS TO TREAT FERRIPROX pharmacy ORAL MISCELLANEOUS AGENT BELZER UW-CSS-VIASPAN medical PERFUSION 3/24/2014 MISCELLANEOUS AGENT DOXERCALCIFEROL medical INTRAVENOUS 3/24/2014 MISCELLANEOUS AGENT DOXERCALCIFEROL pharmacy ORAL 3/24/2014 MISCELLANEOUS AGENT ISOVUE medical INTRAVENOUS 5/8/2014 MISCELLANEOUS AGENT VARITHENA medical INTRAVENOUS 5/8/2014 MISCELLANEOUS AGENT VIMIZIM medical INTRAVENOUS 3/24/2014 MISCELLANEOUS AGENTS CERDELGA pharmacy oral 9/8/2014 MISCELLANEOUS AGENTS MYOVIEW medical INTRAVENOUS 3/6/2015 MISCELLANEOUS AGENTS PARICALCITOL medical INJECTION 12/1/2014 MISCELLANEOUS AGENTS SCULPTRA Not covered INJECTION 9/8/2014 MISCELLANEOUS AGENTS STRENSIQ pharmacy SUBCUTANEOUS 11/10/2015 MISCELLANEOUS ANALGESICS MONOVISC medical INTRAARTICULAR 5/8/2014 MISCELLANEOUS ANALGESICS SUPARTZ FX medical INTRAARTICULAR 10/8/2015 MISCELLANEOUS ANTIINFECTIVES DALVANCE medical INTRAVENOUS 7/7/2014 MISCELLANEOUS ANTIINFECTIVES MEROPENEM-0.9% NACL medical INTRAVENOUS 11/10/2015 MISCELLANEOUS ANTIINFECTIVES ORBACTIV medical INTRAVENOUS 10/9/2014 MISCELLANEOUS ANTIINFECTIVES SIVEXTRO medical INTRAVENOUS 7/7/2014 MISCELLANEOUS ANTINEOPLASTIC DRUGS BELEODAQ medical INTRAVENOUS 8/5/2014 MISCELLANEOUS ANTINEOPLASTIC DRUGS BLINCYTO medical INTRAVENOUS 1/5/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS DOCETAXEL medical INTRAVENOUS 3/6/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS KEYTRUDA medical INTRAVENOUS 10/9/2014 MISCELLANEOUS ANTINEOPLASTIC DRUGS LENVIMA pharmacy ORAL 3/6/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS LONSURF pharmacy ORAL 10/8/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS ODOMZO pharmacy ORAL 10/8/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS ONIVYDE both INTRAVENOUS 11/10/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS OPDIVO medical INTRAVENOUS 1/5/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS SANDOSTATIN LAR DEPOT pharmacy INTRAMUSCULAR 5/6/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS SIGNIFOR LAR both INTRAMUSCULAR 3/6/

13 MISCELLANEOUS ANTINEOPLASTIC DRUGS UNITUXIN medical INTRAVENOUS 8/5/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS YONDELIS medical INTRAVENOUS 11/10/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS ZYDELIG pharmacy ORAL 8/5/2014 MISCELLANEOUS ANTIPSYCHOTICS ABILIFY medical INTRAMUSCULAR 11/10/2015 MISCELLANEOUS ANTIPSYCHOTICS ABILIFY MAINTENA medical INTRAMUSCULAR 11/10/2015 MISCELLANEOUS ANTIPSYCHOTICS ARISTADA medical INTRAMUSCULAR 11/10/2015 MISCELLANEOUS ANTIPSYCHOTICS GEODON IM INJ medical INTRAMUSCULAR 11/10/2015 MISCELLANEOUS ANTIPSYCHOTICS HALDOL DECANOATE medical INTRAMUSCULAR 11/10/2015 MISCELLANEOUS ANTIPSYCHOTICS HALOPERIDOL DECANOATE medical INTRAMUSCULAR 11/10/2015 MISCELLANEOUS ANTIPSYCHOTICS INVEGA SUSTENNA medical INTRAMUSCULAR 11/11/2015 MISCELLANEOUS ANTIPSYCHOTICS INVEGA TRINZA medical INTRAMUSCULAR 7/8/2015 MISCELLANEOUS ANTIPSYCHOTICS OLANZAPINE IM INJ medical INTRAMUSCULAR 11/13/2015 MISCELLANEOUS ANTIPSYCHOTICS RISPERDAL CONSTA medical INTRAMUSCULAR 11/14/2015 MISCELLANEOUS ANTIPSYCHOTICS ZYPREXA IM INJ medical INTRAMUSCULAR 11/15/2015 MISCELLANEOUS ANTIPSYCHOTICS ZYPREXA RELPREVV medical INTRAMUSCULAR 11/16/2015 MISCELLANEOUS ANTIVIRALS DAKLINZA pharmacy ORAL 8/5/2015 MISCELLANEOUS ANTIVIRALS RAPIVAB medical INTRAVENOUS 1/5/2015 MISCELLANEOUS ANTIVIRALS TECHNIVIE pharmacy ORAL 8/5/2015 MISCELLANEOUS COAGULATION AGENTS ALPROLIX both INTRAVENOUS 5/8/2014 MISCELLANEOUS COAGULATION AGENTS BIVALIRUDIN medical INTRAVENOUS 9/10/2015 MISCELLANEOUS COAGULATION AGENTS BIVALIRUDIN medical INTRAVENOUS 9/10/2015 MISCELLANEOUS COAGULATION AGENTS ELOCTATE both INTRAVENOUS 8/5/2014 MISCELLANEOUS COAGULATION AGENTS IXINITY Both INTRAVENOUS 7/8/2015 MISCELLANEOUS COAGULATION AGENTS KCENTRA medical INTRAVENOUS 5/8/2014 MISCELLANEOUS COAGULATION AGENTS NOVOEIGHT Both INTRAVENOUS 4/10/2015 MISCELLANEOUS COAGULATION AGENTS NUWIQ both INTRAVENOUS 11/10/2015 MISCELLANEOUS COAGULATION AGENTS OBIZUR both INTRAVENOUS 12/1/2014 MISCELLANEOUS COAGULATION AGENTS PRAXBIND medical INTRAVENOUS 11/10/2015 MISCELLANEOUS GASTROINTESTINAL AGENTS ENTYVIO medical INTRAVENOUS 6/5/2014 MISCELLANEOUS NEUROLOGICAL THERAPY GLATOPA pharmacy SUBCUTANEOUS 7/8/2015 MISCELLANEOUS NEUROLOGICAL THERAPY LEMTRADA medical INTRAVENOUS 1/5/2015 MISCELLANEOUS NUTRITION PRODUCTS KABIVEN medical INTRAVENOUS 10/9/2014 MISCELLANEOUS NUTRITION PRODUCTS PERIKABIVEN medical INTRAVENOUS 11/4/2014 MISCELLANEOUS NUTRITION PRODUCTS TYR ANAMIX NEXT pharmacy ORAL 10/9/2014 MISCELLANEOUS OPHTHALMOLOGICS OMIDRIA medical INTRAOCULAR 5/6/2015 MISCELLANEOUS PULMONARY AGENTS ORKAMBI pharmacy ORAL 8/5/2015 MISCELLANEOUS PULMONARY AGENTS RUCONEST both INTRAVENOUS 9/8/2014 MISCELLANEOUS RHEUMATOLOGICAL AGENTS RASUVO pharmacy SUBCUTANEOUS 9/8/

14 MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE) XOLAIR pharmacy SUBCUTANEOUS MONOCLONAL ANTIBODY-HUMAN INTERLEUKIN 12/23 INHIB STELARA both SUBCUTANEOUS MOVEMENT DISORDERS (DRUG THERAPY) XENAZINE pharmacy ORAL MUCOLYTICS PULMOZYME pharmacy INHALATION MUSCLE RELAXANTS & ANTISPASMODIC AGENTS METHOCARBAMOL medical INJECTION 1/5/2015 MUSCLE RELAXANTS & ANTISPASMODIC AGENTS RYANODEX medical INTRAVENOUS 9/8/2014 MYASTHENIA GRAVIS NEOSTIGMINE METHYLSULFATE medical INTRAVENOUS 4/10/2015 MYELOID STIMULANTS NEULASTA Delivery Kit medical SUBCUTANEOUS 2/3/2015 MYELOID STIMULANTS ZARXIO both INJECTION 10/8/2015 NARCOTIC ANTAGONISTS EVZIO medical INJECTION 7/7/2014 NARCOTICS MORPHINE SULFATE medical INTRAVENOUS 10/8/2015 NEUROMUSCULAR BLOCKING AGENTS BOTOX medical INJECTION NEUROMUSCULAR BLOCKING AGENTS BOTOX COSMETIC Not covered INJECTION NEUROMUSCULAR BLOCKING AGENTS DYSPORT medical INTRAMUSCULAR NEUROMUSCULAR BLOCKING AGENTS MYOBLOC medical INTRAMUSCULAR NEUROMUSCULAR BLOCKING AGENTS XEOMIN medical INTRAMUSCULAR NSAIDS DYLOJECT medical INTRAVENOUS 9/10/2015 NSAIDS KETOROLAC TROMETHAMINE medical INJECTION 7/7/2014 OCULAR PHOTOACTIVATED VESSEL-OCCLUDING AGENTS VISUDYNE medical INTRAVENOUS OPHTH VASC. ENDOTHELIAL GROWTH FACTOR ANTAGONISTS EYLEA medical INTRAOCULAR OPHTH VASC. ENDOTHELIAL GROWTH FACTOR ANTAGONISTS MACUGEN medical INTRAOCULAR OPHTH. VEGF-A RECEPTOR ANTAG. RCMB MC ANTIBODY LUCENTIS medical INTRAOCULAR ORAL DRUGS FOR GLAUCOMA KEVEYIS pharmacy ORAL 10/8/2015 ORAL MUCOSITIS/STOMATITIS AGENTS MUGARD medical MUCOUS MEMBRANE OTHER ELECTROLYTES ZINC GLUCONATE medical INTRAVENOUS 10/9/2014 PERIODONTAL TETRACYCLINE ANTIINFECTIVE, LOCAL ARESTIN medical DENTAL PHOTOACTIVATED, ANTINEOPLASTIC AGENTS (SYSTEMIC) PHOTOFRIN medical INTRAVENOUS PKU TX AGENT-COFACTOR OF PHENYLALANINE HYDROXYLASE KUVAN pharmacy ORAL PLASMA KALLIKREIN INHIBITORS KALBITOR medical SUBCUTANEOUS PLATELET PROLIFERATION STIMULANTS NEUMEGA pharmacy SUBCUTANEOUS PROGESTATIONAL AGENTS MAKENA medical INTRAMUSCULAR PROGESTATIONAL AGENTS PROGESTERONE medical INTRAMUSCULAR PROTEIN C PREPARATIONS CEPROTIN medical INTRAVENOUS PROTON PUMP INHIBITORS ESOMEPRAZOLE SODIUM medical INTRAVENOUS 3/24/2014 PULM.ANTI-HTN,SEL.C-GMP PHOSPHODIESTERASE T5 INHIB ADCIRCA pharmacy ORAL PULM.ANTI-HTN,SEL.C-GMP PHOSPHODIESTERASE T5 INHIB REVATIO medical INTRAVENOUS PULM.ANTI-HTN,SEL.C-GMP PHOSPHODIESTERASE T5 INHIB SILDENAFIL CITRATE pharmacy ORAL PULM.ANTI-HTN,SEL.C-GMP PHOSPHODIESTERASE T5 INHIB pharmacy ORAL 14

15 PULMONARY ANTI-HTN, ENDOTHELIN RECEPTOR ANTAGONIST LETAIRIS pharmacy ORAL PULMONARY ANTI-HTN, ENDOTHELIN RECEPTOR ANTAGONIST TRACLEER pharmacy ORAL PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE EPOPROSTENOL SODIUM medical INTRAVENOUS PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE FLOLAN medical INTRAVENOUS PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE REMODULIN medical INJECTION PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE TYVASO pharmacy INHALATION PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE VELETRI medical INTRAVENOUS PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE VENTAVIS pharmacy INHALATION RAPID ACTING NITRATES NITRONAL medical INTRAVENOUS 6/5/2014 SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERM) FASLODEX medical INTRAMUSCULAR SOMATOSTATIC AGENTS OCTREOTIDE ACETATE pharmacy INJECTION SOMATOSTATIC AGENTS SANDOSTATIN pharmacy INJECTION 3/24/2014 SOMATOSTATIC AGENTS SANDOSTATIN LAR medical INTRAMUSCULAR 3/24/2014 SOMATOSTATIC AGENTS SOMATULINE DEPOT both SUBCUTANEOUS STEROIDS ILUVIEN medical INTRAOCULAR 1/5/2015 SYSTEMIC ENZYME INHIBITORS ARALAST medical INTRAVENOUS SYSTEMIC ENZYME INHIBITORS ARALAST NP medical INTRAVENOUS SYSTEMIC ENZYME INHIBITORS GLASSIA medical INTRAVENOUS SYSTEMIC ENZYME INHIBITORS PROLASTIN medical INTRAVENOUS SYSTEMIC ENZYME INHIBITORS PROLASTIN C medical INTRAVENOUS SYSTEMIC ENZYME INHIBITORS ZEMAIRA medical INTRAVENOUS THIAZIDE & RELATED DIURETICS ETHACRYNATE SODIUM medical INTRAVENOUS 9/10/2015 THIRD GENERATION CEPHALOSPORINS AVYCAZ medical INTRAVENOUS 5/6/2015 THIRD GENERATION CEPHALOSPORINS ZERBAXA medical INTRAVENOUS 1/5/2015 THROMBIN INHIBITORS,SEL.,DIRECT,&REV.-HIRUDIN TYPE IPRIVASK medical SUBCUTANEOUS THROMBIN INHIBITORS,SEL.,DIRECT,&REV.-HIRUDIN TYPE REFLUDAN medical INTRAVENOUS THROMBOPOIETIN RECEPTOR AGONISTS NPLATE medical SUBCUTANEOUS THROMBOPOIETIN RECEPTOR AGONISTS PROMACTA pharmacy ORAL THYROID FUNCTION DIAGNOSTIC AGENTS THYROGEN medical INTRAMUSCULAR TISSUE BULKING IMPLANTS SOLESTA medical IMPLANTATION TISSUE PROTECTIVE TX OF CHEMOTHERAPY EXTRAVASATION TOTECT medical INTRAVENOUS TOPICAL ANESTHETICS LIVIXIL PAK medical TOPICAL 9/10/2015 TOPICAL ANESTHETICS NAROPIN medical INJECTION 1/5/2015 TOPICAL ANESTHETICS ROPIVACAINE HCL-NS medical INJECTION 8/5/2014 TOPICAL ANESTHETICS ZINGO medical INTRADERMAL 10/8/2015 TOPICAL ANTINEOPLASTIC & PREMALIGNANT LESION AGNTS PANRETIN pharmacy TOPICAL TOXIN-PRODUCING BACILLI VACCINES/TOXOIDS TICE BCG medical INJECTION VACCINES & MISCELLANEOUS IMMUNOLOGICALS AFLURIA both INTRAMUSCULAR 15 9/8/2014

16 VACCINES & MISCELLANEOUS IMMUNOLOGICALS ALTERNARIA medical INJECTION 9/10/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS AMERICAN COCKROACH EXTRACT medical INJECTION 9/10/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS AMERICAN ELM medical INJECTION 9/10/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS ASPERGILLUS FUMIGATUS medical SUBCUTANEOUS 9/10/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS BEXSERO medical INTRAMUSCULAR 3/6/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLUARIX both INTRAMUSCULAR 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLUBLOK both INTRAMUSCULAR 9/8/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLUCELVAX both INTRAMUSCULAR 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLULAVAL both INTRAMUSCULAR 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLUMIST both NASAL 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLUVIRIN both INTRAMUSCULAR 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS FLUZONE both INTRAMUSCULAR 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS GARDASIL 9 both INTRAMUSCULAR 1/5/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS HYQVIA both SUBCUTANEOUS 10/9/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS MIXED RAGWEED EXTRACT medical INJECTION 9/10/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS PNEUMOVAX 23 medical INJECTION 8/5/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS QUADRACEL DTAP-IPV medical INTRAMUSCULAR 5/6/2015 VACCINES & MISCELLANEOUS IMMUNOLOGICALS SINGLE USE EZ FLU both INTRAMUSCULAR 9/8/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS SPHERUSOL medical INTRADERMAL 11/4/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS TRUMENBA medical INTRAMUSCULAR 12/1/2014 VACCINES & MISCELLANEOUS IMMUNOLOGICALS VARIZIG medical INTRAMUSCULAR 7/8/2015 VINCA ALKALOIDS NAVELBINE medical INTRAVENOUS VINCA ALKALOIDS VINBLASTINE SULFATE medical INTRAVENOUS VINCA ALKALOIDS VINCASAR PFS medical INTRAVENOUS VINCA ALKALOIDS VINCRISTINE SULFATE medical INTRAVENOUS VINCA ALKALOIDS VINORELBINE TARTRATE medical INTRAVENOUS VITAMINS & HEMATINICS M.V.I.-12 medical INTRAVENOUS 9/10/2015 VITAMINS & HEMATINICS TRIFERIC medical HEMODIALYSIS 10/8/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS IMLYGIC medical INJECTION 12/7/2015 MISCELLANEOUS PULMONARY AGENTS NUCALA medical SUBCUTANEOUS 12/7/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS COTELLIC pharmacy ORAL 12/7/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS TAGRISSO pharmacy ORAL 12/7/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS DARZALEX medical INTRAVENOUS 12/7/2015 MISCELLANEOUS COAGULATION AGENTS ADYNOVATE medical INTRAVENOUS 12/7/2015 MISCELLANEOUS COAGULATION AGENTS COAGADEX medical INTRAVENOUS 12/7/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS EMPLICITI medical INTRAVENOUS 12/7/2015 MISCELLANEOUS ANTINEOPLASTIC DRUGS NINLARO pharmacy ORAL 12/7/2015 MISCELLANEOUS AGENTS VELTASSA pharmacy ORAL 12/7/

Alameda Alliance for Health SPECIALTY PHARMACY PROGRAM FOR ALLIANCE MEDI-CAL AND GROUP CARE MEMBERS PROGRAM DESCRIPTION

Alameda Alliance for Health SPECIALTY PHARMACY PROGRAM FOR ALLIANCE MEDI-CAL AND GROUP CARE MEMBERS PROGRAM DESCRIPTION Alameda Alliance for Health SPECIALTY PHARMACY PROGRAM FOR ALLIANCE MEDI-CAL AND GROUP CARE MEMBERS PROGRAM DESCRIPTION Contents Page Program Overview 1 Process for Obtaining Authorization 2 Contacts 2

More information

Pain management for cancer patients Acute Ischemic Stroke. Hemophilia, Von willebrand disease & Bleeding disorders. Infectious Disease

Pain management for cancer patients Acute Ischemic Stroke. Hemophilia, Von willebrand disease & Bleeding disorders. Infectious Disease Cigna Specialty Pharmacy Services Limited Distribution and Risk Evaluation Mitigation (RE) Drug List Last updated on 04/06/2015 Medication Brand Name Condition Actemra Rheumatroid Arthritis Acthar Seizure

More information

Specialty Drug Program RX Benefit Member Guide

Specialty Drug Program RX Benefit Member Guide Specialty Drug Program RX Benefit Member Guide bcbsm.com Enrollment Form for Walgreens Specialty Pharmacy, LLC. How to place your initial order with Walgreens Specialty Pharmacy: 1) Print and complete

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE August 20, 2015 SUBJECT EFFECTIVE DATE September 28, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER 99-15-08 BY Specialty Pharmacy Drug Program Pharmacy Services Leesa M. Allen, Deputy Secretary Office

More information

Self-injectable, infused and oral specialty drugs 2014 Aetna Specialty CareRx SM Benefits Plan Drug List

Self-injectable, infused and oral specialty drugs 2014 Aetna Specialty CareRx SM Benefits Plan Drug List Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Self-injectable, infused and oral specialty drugs 2014 Aetna Specialty CareRx SM Benefits Plan Drug List 05.03.382.1

More information

STAT Bulletin. Drug Therapy Guideline Updates. May 11, 2012 Volume: 18 Issue: 12

STAT Bulletin. Drug Therapy Guideline Updates. May 11, 2012 Volume: 18 Issue: 12 STAT Bulletin May 11, 2012 Volume: 18 Issue: 12 To: All primary care physicians and specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat What

More information

encourages correct prescription drug use for a particular diagnosis, promotes the safe use of prescription drugs, and helps reduce drug costs.

encourages correct prescription drug use for a particular diagnosis, promotes the safe use of prescription drugs, and helps reduce drug costs. Prior Authorization Your health plan participates in a Prior Authorization (PA) program for specific prescription drugs. This means that Caremark must review certain information provided by your doctor

More information

N/A N/A N/A. Supporting statement of diagnosis from the N/A. physician and documented trial of 1 generic. formulary alternative

N/A N/A N/A. Supporting statement of diagnosis from the N/A. physician and documented trial of 1 generic. formulary alternative Actimmune Amlodipine Androderm Anticonvulsant Antidepressants Antineoplastics Antipsychotics Arcalyst Butalbital Colony Stimulating Factors ESRD Therapy Actimmune Norvasc Androderm Banzel Keppra Mysoline

More information

Medical Prior Authorization List For prescription drug requirements, see plan formularies.

Medical Prior Authorization List For prescription drug requirements, see plan formularies. For prescription drug requirements, see plan formularies. General Information These requirements are administered by Health First Health Plans ( Health Plans ). Benefits are determined by the plan. Items

More information

CONNECTICARE, INC. & AFFILIATES

CONNECTICARE, INC. & AFFILIATES CONNECTICARE, INC. & AFFILIATES INSERT PAGE FOR PRE-CERTIFICATION AND PRE- AUTHORIZATION LISTS UPDATE Applies to all ConnectiCare health plans, except the ConnectiCare Network USA-PPO Plan and as otherwise

More information

Great-West s Drug Prior Authorization

Great-West s Drug Prior Authorization Great-West s Drug Prior Authorization Great-West Life s prior authorization process is designed to provide an effective approach to managing claims for specific prescription drugs. Approval for coverage

More information

COVERAGE MANAGEMENT PROGRAMS

COVERAGE MANAGEMENT PROGRAMS COVERAGE MANAGEMENT PROGRAMS The purpose of coverage management programs is to help improve the quality of care by encouraging the right patient and provider behaviors to avoid compromised care and unnecessary

More information

UMASTER PREFERRED DRUG LIST (DRUG FORMULARY) Effective July 1, 2015 RA05/15.654

UMASTER PREFERRED DRUG LIST (DRUG FORMULARY) Effective July 1, 2015 RA05/15.654 UMASTER PREFERRED DRUG LIST (DRUG FORMULARY) Effective July 1, 2015 1PU 2PU 3PU 4PU UPU UPU UPU UPU P P P P P Tier Master List (PDL) (Drug Formulary) Effective July 1, 2015 THE BLUEGRASS FAMILY HEALTH

More information

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only Updated 5.5.14 NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only 68152-0103-03 A9543 YTTRIUM Y-90 IBRITUMOMAB TIUXETAN ZEVALIN Y-90 VIAL 9/1/2013 12/31/2013 50419-0320-05

More information

Prescription Drug Benefit Description

Prescription Drug Benefit Description Prescription Drug Benefit Description Herein called Description Prescription Drug Program For State of Kansas Employees Health Plan This booklet describes the Prescription Drug benefits available through

More information

Provider Manual. This manual is to help you learn more about The Ohio State University s medical plans, administered by OSU Health Plan Inc.

Provider Manual. This manual is to help you learn more about The Ohio State University s medical plans, administered by OSU Health Plan Inc. 2014 Provider Manual This manual is to help you learn more about The Ohio State University s medical plans, administered by OSU Health Plan Inc. We hope you find this information and the enclosed documents

More information

Humana 2015 Autorización previa

Humana 2015 Autorización previa Humana 2015 Autorización previa Los medicamentos a continuación requerirán autorización previa en 2015. Para información sobre el nivel de copago, visite Humana.com. Abstral 100 mcg sublingual tablet Abstral

More information

Hydration, IV Infusions, Injections and Vaccine Charge Process

Hydration, IV Infusions, Injections and Vaccine Charge Process There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration

More information

Prior Authorization FID 16157 VER.7 UPDATED 8/2015

Prior Authorization FID 16157 VER.7 UPDATED 8/2015 Prior Authorization FID 16157 VER.7 UPDATED 8/2015 Prior Authorization 2016 MAPD Leon 3 Tier Last Updated: 10/22/2015 ACTEMRA Products Affected Actemra INJ 162MG/0.9ML PA Details Other 1 ACTIMMUNE Products

More information

January 1, 2016 At A Glance. CSEA Civil Service Employees Association

January 1, 2016 At A Glance. CSEA Civil Service Employees Association January 1, 2016 At A Glance CSEA Civil Service Employees Association For Employees of the State of New York represented by Civil Service Employees Association (CSEA) and for their enrolled Dependents;

More information

Drugs Requiring Prior Authorization. Olysio. Subsys. Prolia. Tecfidera

Drugs Requiring Prior Authorization. Olysio. Subsys. Prolia. Tecfidera Abstral Acthar Hp Adcirca Adempas Affinitor Amitiza Amitriptyline Ampyra Androgel Androderm Androxy Aranesp Arcalyst Aubagio Avonex Bosulif Bydureon Byetta Cimzia Cinryze Clomipramine Cometriq Copaxone

More information

Specialty Pharmacy: Understanding the Market and Solution. Your Goals. Presented by Chris Brown November 2009

Specialty Pharmacy: Understanding the Market and Solution. Your Goals. Presented by Chris Brown November 2009 Specialty Pharmacy: Understanding the Market and Solution Presented by Chris Brown November 2009 Your Goals What What is a Specialty is a specialty Medication? medication? Specialty drugs are injectable,

More information

USP Medicare Model Guidelines v6.0 (Categories and Classes)

USP Medicare Model Guidelines v6.0 (Categories and Classes) USP Medicare Model Guidelines v6.0 (Categories and Classes) USP Category Analgesics Nonsteroidal Anti-inflammatory Drugs Opioid Analgesics, Long-acting Opioid Analgesics, Short-acting Anesthetics Local

More information

2016 MDwise HIP Medical Services that Require Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization 2016 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Coding All Out of Network services Facility to facility ambulance transport

More information

REVISING SPECIALTY TIERS

REVISING SPECIALTY TIERS WHITE PAPER REVISING SPECIALTY TIERS PROTECTING MEDICARE PART D BENEFICIARIES FROM BURDENSOME COST SHIFTING Gary G., Michigan Gary thought he had his financial assistance grant set up to cover his out-of-pocket

More information

ICORE Healthcare: Injectable Drug Utilization Management Program Overview for EmblemHealth Providers. May 1, 2012

ICORE Healthcare: Injectable Drug Utilization Management Program Overview for EmblemHealth Providers. May 1, 2012 ICORE Healthcare: Injectable Drug Utilization Management Program Overview for EmblemHealth Providers May 1, 2012 Agenda Topics for Today 1. Program Summary Specialty Injectable Drugs in scope EmblemHealth

More information

Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010

Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010 iltration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010 SUMMARY O CHANGES: Green = Added from literature (Lexi-Comp, Micromedex, pkg inserts) Yellow =

More information

Effective: July 28, 2015. Arizona Prior Authorization Requirements Health Net Access, Inc.

Effective: July 28, 2015. Arizona Prior Authorization Requirements Health Net Access, Inc. Effective: July 28, 2015 Arizona Prior Authorization Requirements Health Net Access, Inc. The following services, procedures and equipment are subject to prior authorization requirements (unless noted

More information

2016 MDwise HIP Medical Services that Require Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization 2016 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Coding All Out of Network services Facility to facility ambulance transport

More information

This information is also available in large print. Call 1-800-286-4242. TTY users should call toll-free 1-800-361-2629.

This information is also available in large print. Call 1-800-286-4242. TTY users should call toll-free 1-800-361-2629. Your prescription drug program 2015 This information is also available in large print. Call 1-800-286-4242. TTY users should call toll-free 1-800-361-2629. Table of Contents Your Prescription Drug Program...

More information

Specialty drug trend

Specialty drug trend 2 0 0 8 Specialty drug trend r e p o r t Specialty Pharmacy A n E x p r e s s S c r i p t s C o m p a n y Lead Authors Emily Cox, PhD, RPh Yakov Svirnovskiy, MA Chris Peterson, PharmD Aimee Tharaldson,

More information

Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment

Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment A Patient s Guide Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is

More information

INPATIENT SERVICES Commercial Medicare. Notification required only, as soon as possible, but no later than 24 hours

INPATIENT SERVICES Commercial Medicare. Notification required only, as soon as possible, but no later than 24 hours Effective: January 1, 2016 Arizona Prior Authorization Requirements HMO (including CommunityCare HMO) Point-of-Service (POS) PPO Advantage (MA) HMO The following services, procedures or equipment are subject

More information

Medicare Part D Drugs that Require Prior-Authorization Effective 12/01/2015

Medicare Part D Drugs that Require Prior-Authorization Effective 12/01/2015 Medicare Drugs that Require Prior- Effective 12/01/2015 Prior Actemra IV Actemra All FDAapproved Required Medical Information Age Prescriber 2. For Rheumatoid Arthritis: Patient must have tried and failed

More information

REFERRAL/AUTHORIZATION GUIDELINES Commercial Plans

REFERRAL/AUTHORIZATION GUIDELINES Commercial Plans Moda Health Referral/Authorization Guidelines Oregon updated September 2014 Page 1 of 7 REFERRAL/AUTHORIZATION GUIDELINES Commercial Plans Referral & Authorization Information Referral and authorization

More information

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication

More information

Fourth Quarter 2014 Provider Connection

Fourth Quarter 2014 Provider Connection Healthy Michigan Plan Health Risk Assessments Do you need clarification or information related to the completion of the Healthy Michigan Plan (HMP) member Health Risk Assessment (HRA) form? Resources and

More information

PATIENT ASSISTANCE PROGRAMS

PATIENT ASSISTANCE PROGRAMS PATIENT ASSISTANCE PROGRAMS Definitions SAP Class I Class II BC Cancer Agency Health Canada Special Access Program Reimbursed for active cancer or approved treatment or approved indication only Reimbursed

More information

Drugs covered under Medicare Part B or Part D

Drugs covered under Medicare Part B or Part D LABEL_NAME GENERIC_NAME MESSAGE GEMZAR INJ 1 GM GEMCITABINE HCL FOR INJ 1 GM ALIMTA INJ 500MG PEMETREXED DISODIUM FOR IV SOLN 500 MG (BASE EQUIV) FUNGIZONE INJ 50MG AMPHOTERICIN B FOR INJ 50 MG KYTRIL

More information

DRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 COVERAGE INFORMATION

DRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 COVERAGE INFORMATION ACTEMRA (toclizumab) 10/21/13 ADASUVE (loxapine aerosol powder breath activated) 01/24/14 ADDAMEL N INJ (Trace Min (CR-CU-F-FE-I-MN-MO-SE-ZN) INJ) 05/20/13 ADYNOVATE (Antihemophilic Factor Recomb Pegylated

More information

Brand Generic J-Code Covered Uses Required Medical Information and Criteria

Brand Generic J-Code Covered Uses Required Medical Information and Criteria FIDELIS CARE NEW YORK DEPARTMENT OF PHARMACY SERVICES J-Code Prior Authorizations & Required Clinical Information Medicaid, Family Health Plus, Child Health Plus, NY State of Health Brand Generic J-Code

More information

Medical School for Actuaries. June 12, 2013. Baltimore, Maryland

Medical School for Actuaries. June 12, 2013. Baltimore, Maryland Medical School for Actuaries June 12, 2013 Baltimore, Maryland Developments in the Treatment of Conditions Treated with Specialty Mediations (Cancer, MS, RA, Hemophilia) Mark S. Matusik, PharmD Developments

More information

Medi-Cal Expansion, Mental Health Services and Changes to Medi-Cal Prior Authorization Requirements

Medi-Cal Expansion, Mental Health Services and Changes to Medi-Cal Prior Authorization Requirements REGULATORY DECEMBER 19, 2013 UPDATE 13-545 12 PAGES Medi-Cal Expansion, Mental Health Services and Changes to Medi-Cal Beginning January 1, 2014, Medi-Cal coverage is expanding under the Affordable Care

More information

Illinois Department of Revenue Regulations TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE

Illinois Department of Revenue Regulations TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE Illinois Department of Revenue Regulations Title 86 Part 530 Section 530.110 Covered Prescription Drugs TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE PART 530 SENIOR CITIZENS AND DISABLED PERSONS

More information

ACTEMRA. Cigna Medicare Rx (PDP) 2014 Cigna Medicare Rx Secure Plan (PDP) Formulary. Products Affected Actemra. Prior Authorization Criteria

ACTEMRA. Cigna Medicare Rx (PDP) 2014 Cigna Medicare Rx Secure Plan (PDP) Formulary. Products Affected Actemra. Prior Authorization Criteria Cigna Medicare Rx (PDP) Medicare Part D Prescription Drug Plans 2014 Cigna Medicare Rx Secure Plan (PDP) Formulary Prior Authorization ACTEMRA Products Affected Actemra PA Details Age Other Authorization

More information

HealthPartners, Inc. 2013 Medicare Part D Formulary ID 13142, Version 22 Prior Authorization Criteria. Last Updated: 11/01/2013

HealthPartners, Inc. 2013 Medicare Part D Formulary ID 13142, Version 22 Prior Authorization Criteria. Last Updated: 11/01/2013 ACTEMRA Actemra (1) DIAGNOSIS OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS, OR (2) JUVENILE IDIOPATHIC ARTHRITIS, AND (3) DOCUMENTATION OF MEDICAL CONTRAINDICATIONS OR FAILURE WITH ENBREL OR HUMIRA.

More information

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No. of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications

More information

Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration

Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration Hospital Pharmacy Volume 42, Number 4, pp 378 382 2007 Wolters Kluwer Health, Inc. Special Resource Drugs to be Used with a Filter for Preparation and/or Administration Prepared by: Wolters Kluwer Health/Facts

More information

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted

More information

A guide to cancer types and chemotherapy medications

A guide to cancer types and chemotherapy medications A guide to cancer types and chemotherapy medications This guides lists words that mean cancer, cancer types and intravenous chemotherapy medications. If you have any questions, see page 10 for details

More information

Prescription Access resources. NeedyMeds. RxAssist.org. Together RX Access 800-444-4106. TogetherRxAccess.com

Prescription Access resources. NeedyMeds. RxAssist.org. Together RX Access 800-444-4106. TogetherRxAccess.com Prescription Access resources NeedyMeds RxAssist.org Together RX Access 800-444-4106 TogetherRxAccess.com The Partnership for Prescription Access 888-4PPA-NOW (888-477-2669) www.pparx.org By Company: ABBOTT

More information

4Precertification. and Referrals. Precertification...59 Referrals (Gated Plans Only)...73

4Precertification. and Referrals. Precertification...59 Referrals (Gated Plans Only)...73 4Precertification and Referrals Precertification.....................59 Referrals (Gated Plans Only)............73 Section 4 Precertification and Referrals 58 www.oxfordhealth.com Precertification and

More information

Safety Policy Manual Policy No. 106

Safety Policy Manual Policy No. 106 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 1 of 11 APPLICATION NYU Langone Medical Center (NYULMC) PURPOSE To protect employees from exposure to hazardous

More information

Pharmacology 260 Online Course Schedule Spring 2012

Pharmacology 260 Online Course Schedule Spring 2012 Pharmacology 260 Online Course Spring 2012 The topics listed below do not necessarily correspond to a 1 - hour lecture period. You should cover the topics for each week at some time during that week. Readings

More information

Items Covered Benefit for Preferred Vendor Contact Information. Medicaid ONLY Integra Phone 718-369-0012

Items Covered Benefit for Preferred Vendor Contact Information. Medicaid ONLY Integra Phone 718-369-0012 Department Of Pharmacy (Medicaid, Child Health Plus, Medicare Part B, Qualified Health Plan) Medications Requiring Authorization under Medical Benefit - Fax request to (718) 536-3383 (Last Revised 8/4/15)

More information

WESTCHESTER COMMUNITY COLLEGE Valhalla, NY 10595. COURSE TITLE: Pharmacology (for Nursing and Health Fields) COURSE NUMBER: Biology 202

WESTCHESTER COMMUNITY COLLEGE Valhalla, NY 10595. COURSE TITLE: Pharmacology (for Nursing and Health Fields) COURSE NUMBER: Biology 202 WESTCHESTER COMMUNITY COLLEGE Valhalla, NY 10595 SYLLABUS FORM COURSE TITLE: Pharmacology (for Nursing and Health Fields) COURSE NUMBER: Biology 202 1. NAME OF COURSE: Pharmacology (for Nursing and Health

More information

Specialty Pipeline Update

Specialty Pipeline Update CLINICAL SOLUTIONS Drug Insights > June 2014 Specialty Pipeline Update New Drug Information Eloctate (recombinant factor VIII Fc fusion protein): Biogen received FDA approval for their hemophilia A for

More information

Medications most likely to be seen in primary care

Medications most likely to be seen in primary care Hazardous Medicines The majority of medicines are not classed as hazardous. The only medicinal products that are automatically deemed to be hazardous are cytotoxic and cytostatic medicines. There is no

More information

Medical Policy and Clinical Guideline Updates

Medical Policy and Clinical Guideline Updates Medical Policy and Clinical Guideline Updates The Medical Policy and Technology Assessment Committee has adopted the following new and/or revised Medical Policies and Clinical Guidelines. Some may have

More information

Cost Differences in Cancer Care Across Settings

Cost Differences in Cancer Care Across Settings Cost Differences in Cancer Care Across Settings August 2013 THE MORAN COMPANY 1 Cost Differences in Cancer Care Across Settings In a prior memorandum, we presented evidence documenting the growing share

More information

APPENDIX: CHEMOTHERAPY SIDE EFFECT PROFILES

APPENDIX: CHEMOTHERAPY SIDE EFFECT PROFILES APPENDIX: CHEMOTHERAPY SIDE EFFECT PROFILES All chemotherapy drugs can cause side effects. No one can predict ahead of time what side effects you may experience or their severity. Some people experience

More information

Inventory of Access and Prices of Orphan Drugs across Europe:

Inventory of Access and Prices of Orphan Drugs across Europe: www.eurordis.org Inventory of Access and Prices of Orphan Drugs across Europe: A Collaborative Work between National Alliances on Rare Diseases & Eurordis Yann Le Cam Chief Executive Officer, EURORDIS

More information

Immune Modulating Drugs Prior Authorization Request Form

Immune Modulating Drugs Prior Authorization Request Form Patient: HPHC member ID #: Requesting provider: Phone: Servicing provider: Diagnosis: Contact for questions (name and phone #): Projected start and end date for requested Requesting provider NPI: Fax:

More information

Cytotoxic and Biotherapies Credentialing Programme Module 2

Cytotoxic and Biotherapies Credentialing Programme Module 2 Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal

More information

Monoclonal antibody (mab) products are currently a fast

Monoclonal antibody (mab) products are currently a fast Antibody Monoclonal Therapeutics Janice M. Reichert, Ph.D. Monoclonal antibody (mab) products are currently a fast growing category of drugs. Like antibodies produced naturally by the human immune system,

More information

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D Coverage and Pricing Elizabeth Hargrave NORC at the University of Chicago Jack Hoadley of Drugs That Can Be Covered Under Part B and Part D Jennifer Thompson Georgetown University MedPAC A study conducted

More information

BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET

BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET Before you begin employment in the role of RN or LPN, you are required to take a Medication Administration Exam. The exam may be administered at

More information

PULMONARY ARTERIAL HYPERTENSION AGENTS

PULMONARY ARTERIAL HYPERTENSION AGENTS Approvable Criteria: PULMONARY ARTERIAL HYPERTENSION AGENTS Brand Name Generic Name Length of Authorization Revatio Sildenafil citrate Calendar Year Adcirca Tadalafil Calendar Year Letairis Ambrisentan

More information

ACNE PRODUCTS. Affected Drugs: Epiduo Retin-A Tretinoin. Covered Uses: All FDA-approved indications not otherwise excluded from Part D

ACNE PRODUCTS. Affected Drugs: Epiduo Retin-A Tretinoin. Covered Uses: All FDA-approved indications not otherwise excluded from Part D ACNE PRODUCTS Epiduo Retin-A Tretinoin Exclusion Criteria: Esthetic purposes N/A N/A TSA 2015 Royal, Classic, Vital and Vital Plus Formulary Page 1 of 148 ACTEMRA Actemra Exclusion Criteria: 1) Active

More information

How Breast Cancer Treatment affects Massage Therapy

How Breast Cancer Treatment affects Massage Therapy How Breast Cancer Treatment affects Massage Therapy A Webinar with Tracy Walton, MS, LMT Part 4 of the More about Cancer Care and Massage Webinar Series 11 Background Tracy Walton Author Educator Researcher

More information

Non-Hodgkin Lymphoma Richard Orlowski, MD

Non-Hodgkin Lymphoma Richard Orlowski, MD Non-Hodgkin Lymphoma Richard Orlowski, MD The American Cancer Society (ACS) estimates that 69,740 Americans will be diagnosed with non-hodgkin lymphoma (NHL) in 2013. Excluding non-melanoma skin cancers,

More information

2013 Prior Authorization (PA) Criteria

2013 Prior Authorization (PA) Criteria 2013 Prior Authorization (PA) Criteria Certain drugs require prior authorization from EmblemHealth Medicare PDP Medicare Plans. This means that your doctor must contact us to get approval before prescribing

More information

Prescription Drug Benefit

Prescription Drug Benefit Prescription Drug Benefit The Cleveland Clinic Employee Health Plan (EHP) Total Care Prescription Drug Benefit is administered through CVS Caremark. CVS Caremark has a dedicated, toll-free Customer Service

More information

22 Medicare Provider Manual

22 Medicare Provider Manual 22 Medicare Provider Manual Table of Contents Title Page Introduction 2 Important Contact Information 4 Member Eligibility & Plan Design 5 ID card sample 8 Provider Reconsideration Process 9 Member Grievance

More information

Prior Authorization Criteria 2014

Prior Authorization Criteria 2014 Prior Authorization Criteria 2014 For information on obtaining an updated coverage determination or an exception to a coverage determination please contact Easy Choice Health Plan of New York s Member

More information

Chemotherapy Drugs: How They Work

Chemotherapy Drugs: How They Work Chemotherapy Drugs: How They Work Chemotherapy is the use of any drug (such as aspirin or penicillin) to treat any disease. But to most people, chemotherapy refers to drugs used for cancer treatment. It

More information

Drugs That Require Prior Authorization (PA) Before Being Approved for Coverage PRIOR AUTHORIZATION MEDICATIONS

Drugs That Require Prior Authorization (PA) Before Being Approved for Coverage PRIOR AUTHORIZATION MEDICATIONS That Require Prior Authorization (PA) Before Being Approved for Coverage PRIOR AUTHORIZATION MEDICATIONS ACNE Approve for those 12 years of age and older AVITA, RETIN-A MICRO, TRETINOIN ACTHAR HP All FDA-approved

More information

Hormones & Hormone Antagonists Chapter 40 - Katzung

Hormones & Hormone Antagonists Chapter 40 - Katzung Hormones & Hormone Antagonists hapter 40 - Katzung Least toxic of anticancer drugs Highly selective Breast, endometrial, prostate cancers 5 ategories Androgens Progestins Antiandrogens Gonadotropin-releasing

More information

Winter 2013. Changing landscapes, pipeline products and plan sponsor impact

Winter 2013. Changing landscapes, pipeline products and plan sponsor impact Winter 2013 Changing landscapes, pipeline products and plan sponsor impact Changing landscapes, pipeline products and plan sponsor impact The pharmaceutical landscape is changing as is the profile of blockbuster

More information

BreastCancerTrials.org History Form: Metastatic Breast Cancer ABOUT ME

BreastCancerTrials.org History Form: Metastatic Breast Cancer ABOUT ME BreastCancerTrials.org History Form: Metastatic Breast Cancer This form is for patients with metastatic breast cancer who were: Were recently diagnosed with metastatic breast cancer (cancer that has spread

More information

BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer ABOUT ME

BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer ABOUT ME BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer This form is for patients with DCIS or early stage invasive cancer who are: On hormone therapy after breast cancer surgery Or

More information

MEDICARE PART B. Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries

MEDICARE PART B. Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries United States Government Accountability Office Report to the Ranking Member, Committee on the Budget, House of Representatives October 2015 MEDICARE PART B Expenditures for New Drugs Concentrated among

More information

Prescription Drug Summary Plan Description

Prescription Drug Summary Plan Description Prescription Drug Summary Plan Description About This Summary Plan Description (SPD) The Prescription Drug Program is a component program in the Tenet Employee Benefit Plan (TEBP). The TEBP is a comprehensive

More information

ASWCS Policy for the Treatment of Extravasation Injury

ASWCS Policy for the Treatment of Extravasation Injury ASWCS Policy for the Treatment of Extravasation Injury Extravasation of Cytotoxic Drugs Introduction 1. The purpose of this policy is to inform practitioners of their responsibilities in relation to preventing

More information

Treating Recurrent Metastatic Breast Cancer

Treating Recurrent Metastatic Breast Cancer BREAST CANCER Treating Recurrent Metastatic Breast Cancer Presented by Julie Gralow, MD Fred Hutchinson Cancer Research Center Generosa Grana, MD UMDNJ/Robert Wood Johnson School of Medicine Patricia Spicer,

More information

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer Breast Studies Adjuvant therapy after surgery Her 2 positive Breast Cancer B 52 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients with Hormone

More information

January 1, 2014. Participating Agencies

January 1, 2014. Participating Agencies January 1, 2014 PA Participating Agencies For Active Employees, Retirees, Vestees and Dependent Survivors, Enrollees covered under Preferred List Provisions, their Dependents, COBRA enrollees and Young

More information

FDA Approved Indications

FDA Approved Indications Preferred Agents: Humatrope (somatropin) Nutropin (somatropin) Medication Nutropin AQ (somatropin) Nutropin AQ NuSpin (somatropin) Non-Preferred Agents: Genotropin (somatropin) Omnitrope (somatropin) Norditropin

More information

Commercial Medicines Unit

Commercial Medicines Unit Commercial Medicines Unit Procurement guidance For The provision of homecare delivery service of medicines to patients at home Issue date: May 2011 Review date: Sep 2012 1 September 2012 Crown Copyright

More information

To start using DocFind today, go to www.aetna.com/docfind/custom/uva. Registration is not required.

To start using DocFind today, go to www.aetna.com/docfind/custom/uva. Registration is not required. Dear University of Virginia Faculty and Staff: Welcome to Aetna! One of the nation's leading health benefits companies, Aetna provides members with information and resources to help you make smart decisions

More information

Contra Costa Regional Medical Center and Health Centers

Contra Costa Regional Medical Center and Health Centers Contra Costa Regional Medical Center and Health Centers Nurse Practitioner Standardized Procedures Table of Contents Definitions..2 References, Purpose, Method of Document Development.. 3 Qualifications,

More information

MEDICAL BENEFIT BOOKLET

MEDICAL BENEFIT BOOKLET MEDICAL BENEFIT BOOKLET For Administered By Si usted necesita ayuda en español para entender este documento, puede solicitarla gratuitamente llamando a Servicios al Cliente al número que se encuentra en

More information

Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services

Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know Ronald Walsh, MD Chief Medical Officer Community Blood Services HEMOSTATIC PROCESS Initiation and formation of the platelet plug

More information

Authorized by the U.S. District Court for the District of Massachusetts

Authorized by the U.S. District Court for the District of Massachusetts Authorized by the U.S. District Court for the District of Massachusetts If you made a Cash Payment or Percentage Co-Payment for Certain Drugs, from January 1, 1991 to March 1, 2008, you may be able to

More information

List of Covered Drugs (Formulary)

List of Covered Drugs (Formulary) Amerigroup STAR+PLUS MMP (Medicare-Medicaid Plan) List of Covered Drugs (Formulary) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Member Services: 1-855-878-1784

More information

BREAST CANCER - METASTATIC & LOCALLY ADVANCED CHEMOTHERAPY REGIMENS Capecitabine. Capecitabine + Docetaxel. Capecitabine + Vinorelbine

BREAST CANCER - METASTATIC & LOCALLY ADVANCED CHEMOTHERAPY REGIMENS Capecitabine. Capecitabine + Docetaxel. Capecitabine + Vinorelbine Capecitabine Capecitabine 1000-1250mg/m 2 oral TWICE daily for 14 days Until disease progression Capecitabine + Docetaxel Capecitabine 750-1000mg/m 2 oral TWICE daily for 14 days Up to 6 cycles Capecitabine

More information

P&T Committee Meeting Minutes (GHP Family Business) March 18, 2014

P&T Committee Meeting Minutes (GHP Family Business) March 18, 2014 P&T Committee Meeting Minutes (GHP Family Business) March 18, 2014 Present: Bret Yarczower, MD, MBA Chair Peter Mikhail, Pharm.D., MBA Secretary Charles Baumgart, MD, MBA Keith Boell, DO Kimberly Clark,

More information

Wendy Clary Nash, PharmD BCPS CPG FASCP. Neil Medical Group Sept 30, 2014

Wendy Clary Nash, PharmD BCPS CPG FASCP. Neil Medical Group Sept 30, 2014 Wendy Clary Nash, PharmD BCPS CPG FASCP Neil Medical Group Sept 30, 2014 Do you feel like You re in a daze? A healthcare craze? A medication maze? Quack, Quack If it walks like a duck, talks like a duck

More information

Approaches to Development of Long Acting Injection Formulations Challenges and Solutions

Approaches to Development of Long Acting Injection Formulations Challenges and Solutions Approaches to Development of Long Acting Injection Formulations Challenges and Solutions Roger G. Harrison PhD Injectable Products, Management Forum, The Institute of Directors, London, 24-25 October 2005

More information